This hypothesis regarding the balance of inflammatory T-cell subsets in defining the disease location might further be extended to explain why some proportion of patients with typical NMO presentation turns out to be negative for AQP4-Ab [37]. The gene discussed is AQP4; the disease is neuromyelitis optica.